Literature DB >> 32270340

Use of Botulinum Toxin in Ophthalmology.

Michael J Wan1,2, Sara AlShaker1, David G Hunter3,4.   

Abstract

Botulinum toxin is an important treatment for many conditions in ophthalmology, including strabismus, nystagmus, blepharospasm, hemifacial spasm, spastic and congenital entropion, corneal exposure, and persistent epithelial defects. The mechanism of action of botulinum toxin for both strabismus and nystagmus is the neuromuscular blockade and transient paralysis of extraocular muscles, but when botulinum toxin is used for some forms of strabismus, a single injection can convey indefinite benefits. There are two unique mechanisms of action that account for the long-term effect on ocular alignment: (1) the disruption of a balanced system of agonist-antagonist extraocular muscles and (2) the reestablishment of central control of alignment by the binocular visual system. For other ocular conditions, botulinum toxin acts through transient paralysis of periocular muscles. Botulinum toxin is a powerful tool in ophthalmology, achieving its therapeutic effects by direct neuromuscular blockade of extraocular and periocular muscles and by unique mechanisms related to the underlying structure and function of the visual system.

Entities:  

Keywords:  Binocular vision; Blepharospasm; Botulinum toxin; Depth perception; Oculomotor muscles; Strabismus

Year:  2021        PMID: 32270340     DOI: 10.1007/164_2019_325

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  44 in total

Review 1.  Chemodenervation for the Treatment of Facial Dystonia: A Report by the American Academy of Ophthalmology.

Authors:  Jurij R Bilyk; Michael T Yen; Elizabeth A Bradley; Edward J Wladis; Louise A Mawn
Journal:  Ophthalmology       Date:  2018-04-10       Impact factor: 12.079

2.  Botulinum toxin A induced protective ptosis.

Authors:  G G Adams; C M Kirkness; J P Lee
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

3.  Treatment of senile entropion with botulinum toxin.

Authors:  J R Clarke; D J Spalton
Journal:  Br J Ophthalmol       Date:  1988-05       Impact factor: 4.638

4.  Role of botulinum toxin A in surgically overcorrected exotropia.

Authors:  E L Dawson; W E Marshman; J P Lee
Journal:  J AAPOS       Date:  1999-10       Impact factor: 1.220

5.  Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

Authors:  Raif Cakmur; Vesile Ozturk; Fatma Uzunel; Beril Donmez; Fethi Idiman
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

6.  The role of botulinum toxin A in acute-onset esotropia.

Authors:  E L Dawson; W E Marshman; G G Adams
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

7.  Botulinum toxin for the treatment of congenital entropion.

Authors:  Gregory Christiansen; Brian G Mohney; Keith H Baratz; Elizabeth A Bradley
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

8.  Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.

Authors:  S Cillino; G Raimondi; N Guépratte; S Damiani; M Cillino; F Di Pace; A Casuccio
Journal:  Eye (Lond)       Date:  2009-07-24       Impact factor: 3.775

9.  Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.

Authors:  Osama H Ababneh; Altug Cetinkaya; Dwight R Kulwin
Journal:  Clin Exp Ophthalmol       Date:  2013-08-04       Impact factor: 4.207

10.  Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients.

Authors:  A Albanese; A R Bentivoglio; C Colosimo; G Galardi; L Maderna; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.